Symbiotec Pharmalab IPO

The Symbiotec Pharmalab IPO is a book-built issue of Rs 1,757 crore, comprising a fresh issue of 0.15 crore shares worth Rs 150 crore and an offer for sale of 1.63 crore shares worth Rs 1,607 crore, opening for subscription from Aug 24 to Aug 27, 2026, with allotment expected on Aug 28, 2026 and a tentative listing on NSE and BSE on Sep 1, 2026. The IPO’s price band is Rs 938 to Rs 988 per share, with a lot size of 15 shares, requiring a minimum retail investment of Rs 14,820. JM Financial Ltd. is the lead manager, and MUFG Intime India Pvt. Ltd. is the registrar for the issue.

Open Demat Account

Symbiotec Pharmalab IPO Details

Check out the issue details for Symbiotec Pharmalab IPO as disclosed in SEBI.

Price Band

₹ 938 - 988

Issue Size

1,757.00 Cr.

Issue Type

Book Built

Open

2026-08-24

Close

2026-08-27

Company Financials

You can get the following financial statements of Symbiotec Pharmalab as of now.

Symbiotec Pharmalab IPO Details

The details about the Symbiotec Pharmalab IPO are as follows:

  • The issue size of the IPO is Rs 1,757.00 Cr.
  • The price band for Symbiotec Pharmalab IPO is Rs 938 to Rs 988.
  • The shares of Symbiotec Pharmalab IPO will list on BSE and NSE.
  • The latest tentative GMP of Symbiotec Pharmalab IPO is Rs .
  • The shares of Symbiotec Pharmalab IPO are subscribed _ Times.

 

Symbiotec Pharmalab IPO Valuation

The approximate valuation of Symbiotec Pharmalab IPO based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 988
Existing Shares (Qty) 6.27 Cr
Fresh Issue Rs 150.00 Cr
Market Cap Rs 6344.76 Cr
EPS (FY25) Rs 19.10
PE Ratio 51.72x
Industry PE 88.32x

 

Symbiotec Pharmalab IPO Issue Size

Symbiotec Pharmalab IPO issue size is Rs 1,757.00 Cr.

Issue Amount
Fresh Issue Rs 150.00 Cr
Offer For Sale Rs 1,607.00 Cr

 

Symbiotec Pharmalab IPO Market Lot

An individual can apply for a minimum of 1 lot of 15 shares and a maximum of 13 lots (195 shares). Find the details below:

Application Lot Shares Amount
Retail Minimum 1 15 Rs 14,820
Retail Maximum 13 195 Rs 1,92,660

 

Symbiotec Pharmalab IPO Share Offer

The shares of Symbiotec Pharmalab IPO are subscribed _ Times. The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Not more than 50%
Non-Institutional Not less than 15%
Retail Individual Not less than 35%

 

Symbiotec Pharmalab IPO GMP (Grey Market Premium)

As on GMP (Tentative)
24 August 2026 Rs

Symbiotec Pharmalab IPO GMP is purely for informational purposes. Invest in an IPO after thoroughly researching on your own.

Symbiotec Pharmalab IPO Dates

Find below the dates for Symbiotec Pharmalab IPO

Schedule Date
Basis of Allotment 28 Aug 2026
Refunds 31 Aug 2026
Credit to Demat Account 31 Aug 2026
IPO Listing Date 01 Sep 2026

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 531.19 622.86 633.85 563.59 673.61
Total Expenditure 411.8 420.5 528.55 483.49 530.67
Operating Profit 119.39 202.37 105.3 80.09 142.94
Other Income 3.17 9.01 5.65 12.37 19.76
Interest 10.61 6.52 3.07 8.05 7.54
Depreciation 21.16 22.18 25.11 27.62 37.26
Exceptional Items 0 0 0 -64.57 0
Profit Before Tax 90.79 182.67 82.77 -7.78 117.9
Provision for Tax 18.27 47.11 21.04 14.88 28.95
Net Profit 72.52 135.56 61.73 -22.66 88.95
Adjusted EPS (Rs.) 1.33 2.48 1.13 -0.41 1.63

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 10.94 10.94 10.94 10.94 10.94
Total Reserves 486.9 622.42 684.25 661.88 750.2
Borrowings 2.47 1.46 0.73 1.41 1.12
Other N/C liabilities 20.7 25.5 26.42 26.71 26.28
Current liabilities 248.56 181.55 172.15 214.19 298.66
Total Liabilities 769.55 841.87 894.48 915.12 1087.19
Assets
Net Block 229.62 247.58 266.09 265.65 323.82
Capital WIP 28.15 26.73 22.62 73.9 19.36
Intangible WIP 2.35 0 0 0 0
Investments 107.1 122.15 130.17 65.6 42.25
Loans & Advances 8.92 30.57 57.48 123.33 200.93
Other N/C Assets 2.32 2.37 2.51 0.01 2.54
Current Assets 391.1 412.46 415.62 386.62 498.29
Total Assets 769.55 841.87 894.48 915.12 1087.19
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024
Profit from operations -7.78 117.9
Adjustment 91.15 25.36
Changes in Assets & Liabilities 25.8 39.29
Tax Paid -15.82 -35.09
Operating Cash Flow 93.35 147.46
Investing Cash Flow -132.5 -80.8
Financing Cash Flow 36.53 -62.98
Net Cash Flow -2.62 3.67
X